Navigation Links
Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
Date:9/14/2009

SAN FRANCISCO, Sept. 14 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported long-term data with vicriviroc, its investigational CCR5 receptor antagonist, from an ongoing, open-label extension of the Phase II VICTOR-E1 study in treatment-experienced HIV-infected patients. The results showed that vicriviroc plus optimized background therapy achieved durable virologic suppression and increased CD4 cell counts, and was generally well tolerated over two years of therapy. These 96-week results were presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).(1)

The study involved 85 treatment-experienced HIV-infected patients who received 48 weeks of open-label vicriviroc (30 mg once daily) plus an optimized antiretroviral regimen containing a ritonavir-boosted protease inhibitor after completion of 48 weeks of treatment in the double-blind phase of the VICTOR-E1 study (total of 96 weeks). More than half of these patients began open-label treatment with undetectable virus, i.e. an HIV-1 RNA level of less than 50 copies/mL, and about two-thirds had less than 400 copies/mL. Seventy patients remained on therapy at the time of the 96-week analysis. The virologic effect seen during the double-blind phase of the study was sustained in these patients during open-label vicriviroc treatment, with the percentage of patients achieving undetectable virus increasing over the course of therapy. Importantly, further improvements in CD4 counts were observed with longer vicriviroc therapy, with a mean increase of 50 cells/mm3 from week 48 of the double-blind study to the end of the 96-week period.

The data also showed that vicriviroc was generally well tolerated in this highly treatment-experienced population.
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
2. Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
3. Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
4. Schering-Plough Announces Results of the Early ACS Trial
5. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
6. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
7. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
8. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
9. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
10. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
11. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 2014 Australian biomarker discovery company Minomic International ... its MiStat™ prostate cancer screening test, planning to achieve ... completion. Minomic,s proprietary MiStat™ technology is a ... proprietary biomarker known as the MIL-38 antigen. This biomarker ... Researchers at 11 leading urology centres ...
(Date:9/18/2014)... YORK , Sept. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced today ... to the position of  Senior Director of Clinical ... Research, Mr. James has established and led successful global ... Europe , to facilitate the clinical development of ...
(Date:9/18/2014)... , Sept. 18, 2014  Spring Bank ... therapeutics for the treatment of RNA viruses, today ... of Health (NIH) for animal testing of the ... pathogens, classified as "Special Pathogens," against which currently ... derived from Spring Bank,s proprietary Small ...
Breaking Medicine Technology:Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Spring Bank Pharmaceuticals Announces NIH Collaboration for Testing of SB 9200 Against Multiple Viral Pathogens 2
... Feb. 16, 2012 Millstone Medical Outsourcing announced today ... CA, and Warsaw, IN.  With new offices positioned in ... will be able to provide customer-specific program development as ... Senior Vice President, will run the San Diego office, ...
... Inc. (PSI), a leading pharmaceutical CRO, announced today that ... oral formulation efforts.  According to Mark Mitchnick, the company,s ... technologies applicable across many dosage forms and drug types.  ... on small molecules of which about 80% fall into ...
Cached Medicine Technology:Millstone Medical Outsourcing Opens Sales Offices in CA, IN 2Particle Sciences Hires Robert Gwozdz to Head Oral Formulation 2
(Date:9/18/2014)... the popular online supplier of funny figurines, has added a ... line. Moreover, all the company’s products are now offered with ... special offer before September 29, 2014. Customers who place bulk ... bobblehead doll ). , “We are pleased to ... make our interesting items available to all the global customers. ...
(Date:9/18/2014)... Hills, CA (PRWEB) September 18, 2014 ... camp, is the fastest-selling fitness business in the country and ... work out, has continued to grow enormously in 2014. ... Camp World Conference, is taking place in Costa Mesa, CA ... one of the biggest conferences yet. Founder Bedros Keuilian, who ...
(Date:9/18/2014)... A positive outlook on life can go ... This year, at the Weekend for Women Conference in Los ... radio talk show host Mother Love will be speaking on ... , The always-funny Jo Anne Hart, aka Mother Love, has ... her widely acclaimed talk show on LATalkRadio.com, which airs weekdays ...
(Date:9/18/2014)... September 18, 2014 How much is ... one of the factors contributing to the obesity epidemic ... a single serving and how to manage portion size ... presentation Oct. 3 at Humility House, 755 Ohltown Road, ... will lead the informational discussion and answer questions from ...
(Date:9/18/2014)... It is true that a business-oriented ... a successful brand or business online. Best Cheap ... compared plenty of professional web hosting suppliers and ... iPage are the best VPS hosting suppliers in ... hosting. All-sized businesses or enterprises can find the ...
Breaking Medicine News(10 mins):Health News:Discounted Custom Bobbleheads Online For Sale At WowBobble.com 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3Health News:DiabetesSisters Showcases Radio Talk Show Host Mother Love at Weekend for Women Conference in Los Angeles 2Health News:HMHP Workshop Addresses Portion Control 2Health News:Best Cheap Hosting USA: GreenGeeks, Arvixe And iPage Are The Best Hosting Suppliers In 2014 2
... last year when he gave the slip to authorities after being ... ailing son. ,He has now been captured, along with ... in Puerto Vallarta on Mexico's Pacific coast, said Deputy U.S. Marshal ... by a federal judge in January 2006 so he could complete ...
... burst into the open in Paris, Dr. Brian Halevie-Goldman, ... months by the// Californian state authorities. ,Dr.Goldman ... Laboratory Co-Operative that allegedly provided steroids to top athletes. ... years' probation and ordered to undergo a psychiatric evaluation ...
... abalone are paying with their lives. Four people perished in ... used in sushi// and a variety of other Asian dishes ... market. ,Abalone are a special type of shellfish ... delicacy in certain parts of Latin America (especially Chile), South ...
... consumer court in Himachal Pradesh has fined the soft drink ... a consumer five years ago//. The complaint was lodged after ... ,The Himachal Pradesh Consumer Redressal Commission here Tuesday asked ... in 2002 by a consumer in Dharamsala, 280 km from ...
... not only protects memories from outside interferences, but also ... looked at memory recall with and without interference (competing ... 30 took part in the study. All had normal, ... Participants were divided evenly into four groups—a wake group ...
... of the body’s genetic repair system may cause Huntington’s ... by destroying their nervous system. Until now, no one ... ,"We showed that when single-strand breaks in ... gene continued to add extra replacement segments," explains Cynthia ...
Cached Medicine News:Health News:Fugitive Who Ditched His Ailing Son Arrested After a Year 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 2Health News:US Psychiatrist Suspended from Practicing Medicine for Involvement in Doping Scam 3Health News:Hunt for Sea Delicacy Taking a Toll in California 2Health News:Hunt for Sea Delicacy Taking a Toll in California 3Health News:Sleep Makes Your Memory Strong 2Health News:Researchers Discovers DNA Repair as Key to Huntington's Disease 2
Hydrophobic PE filter without self-sealing additives, permits sample recovery after accidental over-pipetting. All filters are sterile (to USP, DAB, Ph.Eur. standards) and PCR clean (free from human ...
Ideal for use with low volume samples on the Biomek robotic pipetting systems, the ART 20R provides guaranteed protection for your expensive workstation....
... eliminate false signals and contamination caused ... Promega Barrier Tips offer performance and ... acids (PCR(a)), radioactive isotopes, tissue culture ... specimens. , ,Promega Barrier Tips are ...
... 0.5l - 10l Eppendorf Barrier Tips. Designed to ... reduces the amount of DNA and proteins bound ... advertised as low retention, which means the focus ... tip. However, AvantGard also focuses on low binding ...
Medicine Products: